A detailed history of National Bank Of Canada transactions in Catalent, Inc. stock. As of the latest transaction made, National Bank Of Canada holds 1,460,813 shares of CTLT stock, worth $92.7 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
1,460,813
Previous 1,460,813 -0.0%
Holding current value
$92.7 Million
Previous $88.5 Million -0.0%
% of portfolio
0.12%
Previous 0.12%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$56.16 - $60.96 $61.5 Million - $66.8 Million
1,095,578 Added 299.97%
1,460,813 $88.5 Million
Q2 2024

Aug 02, 2024

BUY
$53.58 - $57.02 $2.46 Million - $2.62 Million
45,877 Added 14.37%
365,235 $20.5 Million
Q1 2024

May 13, 2024

SELL
$42.56 - $59.82 $214,587 - $301,612
-5,042 Reduced 1.55%
319,358 $18 Million
Q4 2023

Feb 06, 2024

BUY
$32.18 - $46.57 $2.18 Million - $3.16 Million
67,894 Added 26.47%
324,400 $14.6 Million
Q3 2023

Oct 10, 2023

SELL
$44.2 - $50.2 $24.5 Million - $27.9 Million
-555,274 Reduced 68.4%
256,506 $11.7 Million
Q2 2023

Jul 26, 2023

BUY
$31.86 - $67.26 $25.5 Million - $53.8 Million
799,427 Added 6471.52%
811,780 $35.2 Million
Q1 2023

Apr 12, 2023

BUY
$45.44 - $74.26 $309,719 - $506,156
6,816 Added 123.1%
12,353 $811,000
Q4 2022

Jan 24, 2023

BUY
$41.39 - $81.0 $176,818 - $346,032
4,272 Added 337.71%
5,537 $0
Q3 2022

Oct 13, 2022

BUY
$72.36 - $113.1 $1,881 - $2,940
26 Added 2.1%
1,265 $95,000
Q2 2022

Jul 28, 2022

SELL
$87.2 - $114.05 $1.3 Million - $1.7 Million
-14,920 Reduced 92.33%
1,239 $136,000
Q1 2022

May 05, 2022

BUY
$94.19 - $124.49 $84,676 - $111,916
899 Added 5.89%
16,159 $1.79 Million
Q4 2021

Jan 24, 2022

BUY
$119.57 - $139.07 $1.82 Million - $2.12 Million
15,260 New
15,260 $1.95 Million

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track National Bank Of Canada Portfolio

Follow National Bank Of Canada and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Bank Of Canada , based on Form 13F filings with the SEC.

News

Stay updated on National Bank Of Canada with notifications on news.